HEADER TRANSFERASE 01-SEP-15 5DIQ
TITLE CRYSTAL STRUCTURE OF HUMAN FPPS IN COMPLEX WITH SALICYLIC ACID
TITLE 2 DERIVATIVE 3A
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: FARNESYL PYROPHOSPHATE SYNTHASE;
COMPND 3 CHAIN: F;
COMPND 4 FRAGMENT: UNP RESIDUES 72-419;
COMPND 5 SYNONYM: FPS,(2E,6E)-FARNESYL DIPHOSPHATE SYNTHASE,
COMPND 6 DIMETHYLALLYLTRANSTRANSFERASE,FARNESYL DIPHOSPHATE SYNTHASE,
COMPND 7 GERANYLTRANSTRANSFERASE;
COMPND 8 EC: 2.5.1.10,2.5.1.1;
COMPND 9 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: FDPS, FPS, KIAA1293;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_VARIANT: TUNER;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28
KEYWDS TRANSFERASE, ISOPRENE BIOSYNTHESIS, CHOLESTEROL BIOSYNTHESIS
EXPDTA X-RAY DIFFRACTION
AUTHOR J.M.RONDEAU,E.BOURGIER,S.LEHMANN
REVDAT 4 08-MAY-24 5DIQ 1 LINK
REVDAT 3 27-JUL-16 5DIQ 1 JRNL
REVDAT 2 04-NOV-15 5DIQ 1 JRNL
REVDAT 1 30-SEP-15 5DIQ 0
JRNL AUTH A.L.MARZINZIK,R.AMSTUTZ,G.BOLD,E.BOURGIER,S.COTESTA,
JRNL AUTH 2 J.F.GLICKMAN,M.GOTTE,C.HENRY,S.LEHMANN,J.C.HARTWIEG,S.OFNER,
JRNL AUTH 3 X.PELLE,T.P.RODDY,J.M.RONDEAU,F.STAUFFER,S.J.STOUT,A.WIDMER,
JRNL AUTH 4 J.ZIMMERMANN,T.ZOLLER,W.JAHNKE
JRNL TITL DISCOVERY OF NOVEL ALLOSTERIC NON-BISPHOSPHONATE INHIBITORS
JRNL TITL 2 OF FARNESYL PYROPHOSPHATE SYNTHASE BY INTEGRATED LEAD
JRNL TITL 3 FINDING.
JRNL REF CHEMMEDCHEM V. 10 1884 2015
JRNL REFN ESSN 1860-7187
JRNL PMID 26381451
JRNL DOI 10.1002/CMDC.201500338
REMARK 1
REMARK 1 REFERENCE 1
REMARK 1 AUTH W.JAHNKE,J.M.RONDEAU,S.COTESTA,A.MARZINZIK,X.PELLE,M.GEISER,
REMARK 1 AUTH 2 A.STRAUSS,M.GOTTE,F.BITSCH,R.HEMMIG,C.HENRY,S.LEHMANN,
REMARK 1 AUTH 3 J.F.GLICKMAN,T.P.RODDY,S.J.STOUT,J.R.GREEN
REMARK 1 TITL ALLOSTERIC NON-BISPHOSPHONATE FPPS INHIBITORS IDENTIFIED BY
REMARK 1 TITL 2 FRAGMENT-BASED DISCOVERY.
REMARK 1 REF NAT.CHEM.BIOL. V. 6 660 2010
REMARK 1 REFN ESSN 1552-4469
REMARK 1 PMID 20711197
REMARK 1 DOI 10.1038/NCHEMBIO.421
REMARK 1 REFERENCE 2
REMARK 1 AUTH W.JAHNKE,G.BOLD,A.MARZINZIK,S.OFNER,X.PELLE,S.COTESTA,
REMARK 1 AUTH 2 E.BOURGIER,S.LEHMANN,C.HENRY,R.HEMMIG,F.STAUFFER,
REMARK 1 AUTH 3 C.MUELLER-HARTWIEG,J.R.GREEN,J.M.RONDEAU
REMARK 1 TITL TUNING BONE AFFINITY INTO NON-BISPHOSPHONATE FPPS
REMARK 1 TITL 2 INHIBITORS: A GENERAL STRATEGY FOR TARGETING DRUGS ACTING ON
REMARK 1 TITL 3 BONE
REMARK 1 REF TO BE PUBLISHED
REMARK 1 REFN
REMARK 2
REMARK 2 RESOLUTION. 2.10 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER-TNT BUSTER 2.11.5
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.09
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5
REMARK 3 NUMBER OF REFLECTIONS : 28758
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.199
REMARK 3 R VALUE (WORKING SET) : 0.198
REMARK 3 FREE R VALUE : 0.216
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.880
REMARK 3 FREE R VALUE TEST SET COUNT : 1403
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 14
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.18
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.52
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2954
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1852
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2819
REMARK 3 BIN R VALUE (WORKING SET) : 0.1840
REMARK 3 BIN FREE R VALUE : 0.2076
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.57
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 135
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2796
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 39
REMARK 3 SOLVENT ATOMS : 200
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 36.42
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.29
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 5.35670
REMARK 3 B22 (A**2) : 5.35670
REMARK 3 B33 (A**2) : -10.71340
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.293
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.186
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.150
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.178
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.147
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 2892 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 3912 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 1017 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 82 ; 2.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 408 ; 5.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 2892 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : 1 ; 5.000 ; SEMIHARMONIC
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 359 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 3560 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 0.90
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.77
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.20
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 1
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 SELECTION: { F|* }
REMARK 3 ORIGIN FOR THE GROUP (A): 10.4008 80.2631 27.7210
REMARK 3 T TENSOR
REMARK 3 T11: -0.1563 T22: -0.1401
REMARK 3 T33: -0.0700 T12: -0.0128
REMARK 3 T13: 0.0125 T23: 0.0086
REMARK 3 L TENSOR
REMARK 3 L11: 1.7913 L22: 1.1609
REMARK 3 L33: 1.5084 L12: 0.6093
REMARK 3 L13: -1.0749 L23: -0.5559
REMARK 3 S TENSOR
REMARK 3 S11: -0.0649 S12: -0.1039 S13: -0.1408
REMARK 3 S21: 0.0085 S22: 0.0313 S23: 0.1342
REMARK 3 S31: 0.1072 S32: -0.0042 S33: 0.0335
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 5DIQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-SEP-15.
REMARK 100 THE DEPOSITION ID IS D_1000213265.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 16-NOV-04
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 5.3
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178
REMARK 200 MONOCHROMATOR : MIRRORS
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 92
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28921
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 200 DATA REDUNDANCY : 13.50
REMARK 200 R MERGE (I) : 0.09900
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.4000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18
REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0
REMARK 200 DATA REDUNDANCY IN SHELL : 9.90
REMARK 200 R MERGE FOR SHELL (I) : 0.44700
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: CNX 2002
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 58.70
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.98
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 1.2M SODIUM POTASSIUM PHOSPHATE, 25%
REMARK 280 GLYCEROL, PH 5.3, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 292K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4
REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4
REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4
REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4
REMARK 290 7555 Y,X,-Z
REMARK 290 8555 -Y,-X,-Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.41750
REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 55.81450
REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 55.81450
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 19.20875
REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 55.81450
REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 55.81450
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 57.62625
REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 55.81450
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.81450
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 19.20875
REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 55.81450
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.81450
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 57.62625
REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 38.41750
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 6210 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 29310 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -55.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: F
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 2 0.000000 -1.000000 0.000000 111.62900
REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 111.62900
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 38.41750
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLY F 4
REMARK 465 PRO F 5
REMARK 465 ASN F 6
REMARK 465 SER F 7
REMARK 465 LYS F 353
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLN F 77 56.04 -92.98
REMARK 500 VAL F 124 -74.70 -97.78
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 MG F 404 MG
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASP F 243 OD2
REMARK 620 2 HOH F 531 O 174.5
REMARK 620 3 HOH F 545 O 94.9 85.6
REMARK 620 4 HOH F 551 O 88.7 85.9 89.0
REMARK 620 5 HOH F 653 O 90.3 95.2 82.9 171.7
REMARK 620 6 HOH F 662 O 95.6 84.0 169.5 91.4 96.9
REMARK 620 N 1 2 3 4 5
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue GOL F 401
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue GOL F 402
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 5B9 F 403
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue MG F 404
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 F 405
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 5DGN RELATED DB: PDB
REMARK 900 HUMAN FPPS COMPLEX WITH BIARYL COMPOUND 8A
DBREF 5DIQ F 6 353 UNP P14324 FPPS_HUMAN 72 419
SEQADV 5DIQ GLY F 4 UNP P14324 EXPRESSION TAG
SEQADV 5DIQ PRO F 5 UNP P14324 EXPRESSION TAG
SEQRES 1 F 350 GLY PRO ASN SER ASP VAL TYR ALA GLN GLU LYS GLN ASP
SEQRES 2 F 350 PHE VAL GLN HIS PHE SER GLN ILE VAL ARG VAL LEU THR
SEQRES 3 F 350 GLU ASP GLU MET GLY HIS PRO GLU ILE GLY ASP ALA ILE
SEQRES 4 F 350 ALA ARG LEU LYS GLU VAL LEU GLU TYR ASN ALA ILE GLY
SEQRES 5 F 350 GLY LYS TYR ASN ARG GLY LEU THR VAL VAL VAL ALA PHE
SEQRES 6 F 350 ARG GLU LEU VAL GLU PRO ARG LYS GLN ASP ALA ASP SER
SEQRES 7 F 350 LEU GLN ARG ALA TRP THR VAL GLY TRP CYS VAL GLU LEU
SEQRES 8 F 350 LEU GLN ALA PHE PHE LEU VAL ALA ASP ASP ILE MET ASP
SEQRES 9 F 350 SER SER LEU THR ARG ARG GLY GLN ILE CYS TRP TYR GLN
SEQRES 10 F 350 LYS PRO GLY VAL GLY LEU ASP ALA ILE ASN ASP ALA ASN
SEQRES 11 F 350 LEU LEU GLU ALA CYS ILE TYR ARG LEU LEU LYS LEU TYR
SEQRES 12 F 350 CYS ARG GLU GLN PRO TYR TYR LEU ASN LEU ILE GLU LEU
SEQRES 13 F 350 PHE LEU GLN SER SER TYR GLN THR GLU ILE GLY GLN THR
SEQRES 14 F 350 LEU ASP LEU LEU THR ALA PRO GLN GLY ASN VAL ASP LEU
SEQRES 15 F 350 VAL ARG PHE THR GLU LYS ARG TYR LYS SER ILE VAL LYS
SEQRES 16 F 350 TYR LYS THR ALA PHE TYR SER PHE TYR LEU PRO ILE ALA
SEQRES 17 F 350 ALA ALA MET TYR MET ALA GLY ILE ASP GLY GLU LYS GLU
SEQRES 18 F 350 HIS ALA ASN ALA LYS LYS ILE LEU LEU GLU MET GLY GLU
SEQRES 19 F 350 PHE PHE GLN ILE GLN ASP ASP TYR LEU ASP LEU PHE GLY
SEQRES 20 F 350 ASP PRO SER VAL THR GLY LYS ILE GLY THR ASP ILE GLN
SEQRES 21 F 350 ASP ASN LYS CYS SER TRP LEU VAL VAL GLN CYS LEU GLN
SEQRES 22 F 350 ARG ALA THR PRO GLU GLN TYR GLN ILE LEU LYS GLU ASN
SEQRES 23 F 350 TYR GLY GLN LYS GLU ALA GLU LYS VAL ALA ARG VAL LYS
SEQRES 24 F 350 ALA LEU TYR GLU GLU LEU ASP LEU PRO ALA VAL PHE LEU
SEQRES 25 F 350 GLN TYR GLU GLU ASP SER TYR SER HIS ILE MET ALA LEU
SEQRES 26 F 350 ILE GLU GLN TYR ALA ALA PRO LEU PRO PRO ALA VAL PHE
SEQRES 27 F 350 LEU GLY LEU ALA ARG LYS ILE TYR LYS ARG ARG LYS
HET GOL F 401 6
HET GOL F 402 6
HET 5B9 F 403 21
HET MG F 404 1
HET PO4 F 405 5
HETNAM GOL GLYCEROL
HETNAM 5B9 2-(NAPHTHALEN-1-YLMETHOXY)BENZOIC ACID
HETNAM MG MAGNESIUM ION
HETNAM PO4 PHOSPHATE ION
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 2 GOL 2(C3 H8 O3)
FORMUL 4 5B9 C18 H14 O3
FORMUL 5 MG MG 2+
FORMUL 6 PO4 O4 P 3-
FORMUL 7 HOH *200(H2 O)
HELIX 1 AA1 ASP F 8 THR F 29 1 22
HELIX 2 AA2 HIS F 35 GLU F 37 5 3
HELIX 3 AA3 ILE F 38 ILE F 54 1 17
HELIX 4 AA4 TYR F 58 VAL F 72 1 15
HELIX 5 AA5 ASP F 78 ASP F 107 1 30
HELIX 6 AA6 TRP F 118 LYS F 121 5 4
HELIX 7 AA7 VAL F 124 LEU F 126 5 3
HELIX 8 AA8 ASP F 127 ARG F 148 1 22
HELIX 9 AA9 TYR F 152 ALA F 178 1 27
HELIX 10 AB1 ASP F 184 PHE F 188 5 5
HELIX 11 AB2 THR F 189 THR F 201 1 13
HELIX 12 AB3 THR F 201 PHE F 206 1 6
HELIX 13 AB4 PHE F 206 ALA F 217 1 12
HELIX 14 AB5 GLY F 221 GLY F 250 1 30
HELIX 15 AB6 ASP F 251 GLY F 256 1 6
HELIX 16 AB7 SER F 268 ALA F 278 1 11
HELIX 17 AB8 THR F 279 TYR F 290 1 12
HELIX 18 AB9 GLU F 294 LEU F 308 1 15
HELIX 19 AC1 ASP F 309 ALA F 333 1 25
HELIX 20 AC2 PRO F 338 LYS F 350 1 13
SHEET 1 AA1 2 THR F 111 ARG F 112 0
SHEET 2 AA1 2 GLN F 115 ILE F 116 -1 O GLN F 115 N ARG F 112
LINK OD2 ASP F 243 MG MG F 404 1555 1555 2.18
LINK MG MG F 404 O HOH F 531 1555 1555 2.30
LINK MG MG F 404 O HOH F 545 1555 1555 1.94
LINK MG MG F 404 O HOH F 551 1555 1555 2.06
LINK MG MG F 404 O HOH F 653 1555 1555 2.17
LINK MG MG F 404 O HOH F 662 1555 1555 2.06
CISPEP 1 ALA F 334 PRO F 335 0 7.51
SITE 1 AC1 8 ARG F 141 LYS F 144 GLU F 158 LEU F 161
SITE 2 AC1 8 GLN F 162 HOH F 512 HOH F 536 HOH F 540
SITE 1 AC2 4 ASP F 174 GLN F 240 ASP F 244 CYS F 267
SITE 1 AC3 12 LYS F 57 ASN F 59 ARG F 60 THR F 63
SITE 2 AC3 12 SER F 205 PHE F 206 PHE F 239 LEU F 344
SITE 3 AC3 12 ILE F 348 PO4 F 405 HOH F 503 HOH F 508
SITE 1 AC4 6 ASP F 243 HOH F 531 HOH F 545 HOH F 551
SITE 2 AC4 6 HOH F 653 HOH F 662
SITE 1 AC5 9 GLY F 56 LYS F 57 GLN F 96 ARG F 113
SITE 2 AC5 9 5B9 F 403 HOH F 503 HOH F 515 HOH F 548
SITE 3 AC5 9 HOH F 574
CRYST1 111.629 111.629 76.835 90.00 90.00 90.00 P 41 21 2 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.008958 0.000000 0.000000 0.00000
SCALE2 0.000000 0.008958 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013015 0.00000